Cromos Pharma supporting psoriasis clinical research breakthroughs August is Psoriasis Awareness Month. Cromos Pharma is using this opportunity to underline its commitment to supporting clinical trials to develop new and innovative treatments to improve the lives of millions of psoriasis sufferers around the world. Immune disorder affecting 125 million people worldwide Psoriasis is a complex immune system disorder in which white blood cells,
What will the upcoming Clinical Trial Regulation mean for the conduct of trials in the EU? The long-awaited European Union (EU) Clinical Trial Regulation (Regulation (EU) No 536/2014) (CTR) will come into effect in early 2022. The CTR is intended to improve the submission and review processes for clinical trials via a centralized portal. In recent weeks, the European Medicines Agency (EMA) has confirmed that the clinical trial EU Portal and Database, the
Cromos Pharma on the upcoming implementation of EU Clinical Trial Regulation The long-awaited European Union (EU) Clinical Trial Regulation (Regulation (EU) No 536/2014) (CTR) will come into effect in early 2022. The CTR is intended to improve the submission and review processes for clinical trials via a centralized portal. In recent weeks, the European Medicines Agency (EMA) has confirmed that the clinical trial EU Portal and Database, the
